Visual Abstract

Aims: Percutaneous coronary intervention is routinely performed to treat occlusive coronary artery disease. Coronary perforation is a potential complication and can be treated with a stent graft. Current stent grafts are associated with high restenosis rates. We tested the safety and feasibility of biodegradable stent grafts in pig and rabbit models. Methods and Results: Stent grafts were examined in pig coronaries with repeated OCT imaging for 42 days. Novel biodegradable coatings were applied on a bare metal stent by either an electrospinning (ES) or dip coating (DC) method. A completely biodegradable system was made by ES coating a magnesium-based stent. A commercially available stent graft served as a control. ES devices showed less restenosis (44.3 ± 8.8 vs. 59.1 ± 11.1% in controls, p < 0.05) and smaller reduction in minimum lumen area (44.3 ± 13.4 vs. 64.4 ± 13.6% in controls, p < 0.05) at day 42. DC devices occluded during follow-up. ES devices showed recanalization through the graft wall at day 42. Feasibility of the ES and DC devices was evaluated in pig coronary aneurysms and rabbit aortic perforation models and sealed aneurysms and perforations without complications. Conclusions: Recanalization of the graft wall improves biocompatibility. Biodegradable stent grafts may present an alternative to permanent implants by showing reduced restenosis at day 42.

1.
Stefanini
GG
,
Holmes
DR
 Jr
.
Drug-eluting coronary-artery stents
.
N Engl J Med
.
2013
Jan
;
368
(
3
):
254
65
.
[PubMed]
0028-4793
2.
Rodriguez-Santamarta
M
,
Estevez-Loureiro
R
,
Cuellas
C
,
Benito-Gonzalez
T
,
Perez de Prado
A
,
Lopez-Benito
M
,
Fernandez-Vazquez
F.
Double Guide Catheter Technique for Sealing an Iatrogenic Coronary Perforation.
Research in Cardiovascular Medicine.
2016
March 5 5;5(2):e31388.
3.
Martí
V
,
Castaño
C
,
Guiteras
P
,
Vallés
E
,
Domínguez de Rozas
JM
,
Augé
JM
.
[Cardiac perforation complicated by cardiac tamponade and sealed with metallic coils]
.
Rev Esp Cardiol
.
2004
Oct
;
57
(
10
):
990
2
.
[PubMed]
0300-8932
4.
Elsner
M
,
Zeiher
AM
.
[Perforation and rupture of coronary arteries]
.
Herz
.
1998
Aug
;
23
(
5
):
311
8
.
[PubMed]
0340-9937
5.
Patel
VG
,
Brayton
KM
,
Tamayo
A
,
Mogabgab
O
,
Michael
TT
,
Lo
N
, et al.
Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies
.
JACC Cardiovasc Interv
.
2013
Feb
;
6
(
2
):
128
36
.
[PubMed]
1936-8798
6.
Kinnaird
T
,
Kwok
CS
,
Kontopantelis
E
,
Ossei-Gerning
N
,
Ludman
P
,
deBelder
M
, et al.;
British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research
.
Incidence, Determinants, and Outcomes of Coronary Perforation During Percutaneous Coronary Intervention in the United Kingdom Between 2006 and 2013: An Analysis of 527 121 Cases From the British Cardiovascular Intervention Society Database
.
Circ Cardiovasc Interv
.
2016
Aug
;
9
(
8
):
e003449
.
[PubMed]
1941-7640
7.
Ylä-Herttuala
S
,
Bentzon
JF
,
Daemen
M
,
Falk
E
,
Garcia-Garcia
HM
,
Herrmann
J
, et al.;
ESC Working Group of Atherosclerosis and Vascular Biology
.
Stabilization of atherosclerotic plaques: an update
.
Eur Heart J
.
2013
Nov
;
34
(
42
):
3251
8
.
[PubMed]
0195-668X
8.
Yeo
KK
,
Rogers
JH
,
Laird
JR
.
Use of stent grafts and coils in vessel rupture and perforation
.
J Interv Cardiol
.
2008
Feb
;
21
(
1
):
86
99
.
[PubMed]
0896-4327
9.
Röther
J
,
Tröbs
M
,
Ludwig
J
,
Achenbach
S
,
Schlundt
C
.
Treatment and outcome of coronary artery perforations using a dual guiding catheter technique
.
Int J Cardiol
.
2015
Dec
;
201
(
December
):
479
83
.
[PubMed]
0167-5273
10.
Gercken
U
,
Lansky
AJ
,
Buellesfeld
L
,
Desai
K
,
Badereldin
M
,
Mueller
R
, et al.
Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results
.
Catheter Cardiovasc Interv
.
2002
Jul
;
56
(
3
):
353
60
.
[PubMed]
1522-1946
11.
Briguori
C
,
Nishida
T
,
Anzuini
A
,
Di Mario
C
,
Grube
E
,
Colombo
A
.
Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures
.
Circulation
.
2000
Dec
;
102
(
25
):
3028
31
.
[PubMed]
0009-7322
12.
Al-Mukhaini
M
,
Panduranga
P
,
Sulaiman
K
,
Riyami
AA
,
Deeb
M
,
Riyami
MB
.
Coronary perforation and covered stents: an update and review
.
Heart Views
.
2011
Apr
;
12
(
2
):
63
70
.
[PubMed]
1995-705X
13.
Guttmann
OP
,
Jones
DA
,
Gulati
A
,
Kotecha
T
,
Fayed
H
,
Patel
D
, et al.
Prevalence and outcomes of coronary artery perforation during percutaneous coronary intervention
.
EuroIntervention
.
2017
Aug
;
13
(
5
):
e595
601
.
[PubMed]
1774-024X
14.
Eeckhout
E
,
De Palma
R
.
Coronary perforation: an inconvenient complication
.
JACC Cardiovasc Interv
.
2011
Jan
;
4
(
1
):
96
7
.
[PubMed]
1936-8798
15.
Romaguera
R
,
Waksman
R
.
Covered stents for coronary perforations: is there enough evidence?
Catheter Cardiovasc Interv
.
2011
Aug
;
78
(
2
):
246
53
.
[PubMed]
1522-1946
16.
Elsner
M
,
Auch-Schwelk
W
,
Britten
M
,
Walter
DH
,
Schächinger
V
,
Zeiher
AM
.
Coronary stent grafts covered by a polytetrafluoroethylene membrane.
The American Journal of Cardiology,
1999
August 1;84:335-8, A8.
17.
Takano
M
,
Yamamoto
M
,
Inami
S
,
Xie
Y
,
Murakami
D
,
Okamatsu
K
, et al.
Delayed endothelialization after polytetrafluoroethylene-covered stent implantation for coronary aneurysm
.
Circ J
.
2009
Jan
;
73
(
1
):
190
3
.
[PubMed]
1346-9843
18.
Serruys
PW
,
Onuma
Y
,
Garcia-Garcia
HM
,
Muramatsu
T
,
van Geuns
RJ
,
de Bruyne
B
, et al.
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
.
EuroIntervention
.
2014
Mar
;
9
(
11
):
1271
84
.
[PubMed]
1774-024X
19.
Gogas
BD
,
Benham
JJ
,
Hsu
S
,
Sheehy
A
,
Lefer
DJ
,
Goodchild
TT
, et al.
Vasomotor Function Comparative Assessment at 1 and 2 Years Following Implantation of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold and the Xience V Everolimus-Eluting Metallic Stent in Porcine Coronary Arteries: Insights From In Vivo Angiography, Ex Vivo Assessment, and Gene Analysis at the Stented/Scaffolded Segments and the Proximal and Distal Edges
.
JACC Cardiovasc Interv
.
2016
Apr
;
9
(
7
):
728
41
.
[PubMed]
1936-8798
20.
Bil
J
,
Gil
RJ
.
Bioresorbable vascular scaffolds-what does the future bring?
J Thorac Dis
.
2016
Aug
;
8
(
8
):
E741
5
.
[PubMed]
2072-1439
21.
Bräsen
JH
,
Kivelä
A
,
Röser
K
,
Rissanen
TT
,
Niemi
M
,
Luft
FC
, et al.
Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries
.
Arterioscler Thromb Vasc Biol
.
2001
Nov
;
21
(
11
):
1720
6
.
[PubMed]
1079-5642
22.
Schwartz
RS
,
Huber
KC
,
Murphy
JG
,
Edwards
WD
,
Camrud
AR
,
Vlietstra
RE
, et al.
Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model
.
J Am Coll Cardiol
.
1992
Feb
;
19
(
2
):
267
74
.
[PubMed]
0735-1097
23.
Kornowski
R
,
Hong
MK
,
Tio
FO
,
Bramwell
O
,
Wu
H
,
Leon
MB
.
In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia
.
J Am Coll Cardiol
.
1998
Jan
;
31
(
1
):
224
30
.
[PubMed]
0735-1097
24.
Asano
T
,
Hytönen
J
,
Chichareon
P
,
Taavitsainen
J
,
Kogame
N
,
Katagiri
Y
, et al.
Serial Optical Coherence Tomography at Baseline, 7 Days, and 1, 3, 6 and 12 Months After Bioresorbable Scaffold Implantation in a Growing Porcine Model
.
Circ J
.
2019
Feb
;
83
(
3
):
556
66
.
[PubMed]
1346-9843
25.
Hytönen
JP
,
Taavitsainen
J
,
Tarvainen
S
,
Ylä-Herttuala
S
.
Biodegradable coronary scaffolds: their future and clinical and technological challenges
.
Cardiovasc Res
.
2018
Jul
;
114
(
8
):
1063
72
.
[PubMed]
0008-6363
26.
Waksman
R
,
Zumstein
P
,
Pritsch
M
,
Wittchow
E
,
Haude
M
,
Lapointe-Corriveau
C
, et al.
Second-generation magnesium scaffold Magmaris: device design and preclinical evaluation in a porcine coronary artery model
.
EuroIntervention
.
2017
Jul
;
13
(
4
):
440
9
.
[PubMed]
1774-024X
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.